Publication | Open Access

Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression

Cell-based Drug DeliveryNanomedicineDrug TargetingEngineeringGlioblastoma MultiformePolymer-drug ConjugateMedicineTargeted Drug DeliveryVivo Tumor ProgressionTumor TargetingNano-drug DeliveryBiomedical EngineeringPharmacologyGliomaVitro Cell Growth